Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,176
datasets available to search
ShareScore release 0.9.0
Dataset results
1,176 results for “ulcerative colitis”
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02531126. IPD Sharing: Not stated. Countries: 20. Publications: 6.
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis
ClinicalTrials.gov study NCT01831427. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
ClinicalTrials.gov study NCT01059344. IPD Sharing: NO. Countries: 4. Publications: 1.
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
ClinicalTrials.gov study NCT02497469. IPD Sharing: YES. Countries: 34. Publications: 3.
Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02895100. IPD Sharing: UNDECIDED. Countries: 17. Publications: 1.
A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis
ClinicalTrials.gov study NCT00336492. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT00783718. IPD Sharing: Not stated. Countries: 3. Publications: 14.
A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)
ClinicalTrials.gov study NCT04996797. IPD Sharing: YES. Countries: 12. Publications: 1.
A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.
ClinicalTrials.gov study NCT00787202. IPD Sharing: Not stated. Countries: 17. Publications: 19.
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02065557. IPD Sharing: YES. Countries: 14. Publications: 1.
Nicotinamide Riboside in Ulcerative Colitis
ClinicalTrials.gov study NCT05561738. IPD Sharing: YES. Countries: 1. Publications: 9.
Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis
ClinicalTrials.gov study NCT01171807. IPD Sharing: Not stated. Countries: 1. Publications: 1.
(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
ClinicalTrials.gov study NCT00679380. IPD Sharing: Not stated. Countries: 15. Publications: 1.
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT05528510. IPD Sharing: YES. Countries: 25. Publications: 1.
Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT02914522. IPD Sharing: NO. Countries: 40. Publications: 11.
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
ClinicalTrials.gov study NCT03341962. IPD Sharing: UNDECIDED. Countries: 19. Publications: 1.
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
ClinicalTrials.gov study NCT03518086. IPD Sharing: YES. Countries: 35. Publications: 9.
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
ClinicalTrials.gov study NCT01620255. IPD Sharing: Not stated. Countries: 21. Publications: 2.
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT03290781. IPD Sharing: Not stated. Countries: 37. Publications: 1.
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
ClinicalTrials.gov study NCT00385736. IPD Sharing: Not stated. Countries: 13. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.